Aeromonas veronii strain in the intestinal tract of shrimp and application thereof in shrimp culture
By using the BG12 strain of Adhesium tumefaciens from the shrimp gut as a probiotic additive, the problems of microbial ecological imbalance and frequent disease outbreaks in shrimp farming were solved, and the effects of improving growth and disease resistance were achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NINGBO UNIV
- Filing Date
- 2023-04-18
- Publication Date
- 2026-07-10
AI Technical Summary
In existing technologies, the deterioration of water quality in shrimp farming leads to an imbalance in the microbial ecosystem and intestinal flora, which easily causes diseases. Furthermore, the use of antibiotics leads to drug resistance and health risks, and there is a lack of effective disease-resistant and growth-promoting microbial agents.
The BG12 strain of *Actobacter spp.* from the intestinal tract of shrimp, which has amylase and cellulase activities, was used to prepare a probiotic additive to regulate the intestinal flora and improve immunity and disease resistance.
It improves the growth and disease resistance of shrimp, maintains the microecological balance of the aquaculture system, reduces the risk of disease, and replaces the use of traditional antibiotics.
Smart Images

Figure CN117327600B_ABST